Reneo Pharmaceuticals, Inc. - stock earnings
RPHM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -19.2 million USD | ? USD |
| 2023Q2 | -19.5 million USD | ? USD |
| 2023Q1 | -14.1 million USD | ? USD |
| 2022Q4 | -12.6 million USD | ? USD |
| 2022Q3 | -12.2 million USD | ? USD |
| 2022Q2 | -12.2 million USD | ? USD |
| 2022Q1 | -13.1 million USD | ? USD |
| 2021Q4 | -10.6 million USD | ? USD |
| 2021Q3 | -12.7 million USD | ? USD |
| 2021Q2 | -9.2 million USD | ? USD |
| 2021Q1 | -7.2 million USD | ? USD |
| 2020Q4 | -6.3 million USD | ? USD |
| 2020Q3 | -5.1 million USD | ? USD |
| 2020Q2 | -3.7 million USD | ? USD |
| 2020Q1 | -4.4 million USD | ? USD |
RPHM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -67.4 million USD | ? USD |
| 2022 | -50.1 million USD | ? USD |
| 2021 | -39.8 million USD | ? USD |
| 2020 | -19.5 million USD | ? USD |
| 2019 | -12.4 million USD | ? USD |
RPHM
Price: $1.73
52 week price:
Earnings Per Share: -2.52 USD
P/E Ratio: -0.74
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 37300
Market Capitalization: 56.1 million